FR1407M - New drug, especially for the treatment of spasms of vascular origin. - Google Patents

New drug, especially for the treatment of spasms of vascular origin.

Info

Publication number
FR1407M
FR1407M FR859596A FR859596A FR1407M FR 1407 M FR1407 M FR 1407M FR 859596 A FR859596 A FR 859596A FR 859596 A FR859596 A FR 859596A FR 1407 M FR1407 M FR 1407M
Authority
FR
France
Prior art keywords
spasms
treatment
new drug
vascular origin
vascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR859596A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR859596A priority Critical patent/FR1407M/en
Priority to BE616479A priority patent/BE616479A/en
Priority to US188226A priority patent/US3165444A/en
Priority to GB15631/62A priority patent/GB1014052A/en
Application granted granted Critical
Publication of FR1407M publication Critical patent/FR1407M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M8/00—Fuel cells; Manufacture thereof
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M8/00—Fuel cells; Manufacture thereof
    • H01M8/06—Combination of fuel cells with means for production of reactants or for treatment of residues
    • H01M8/0606—Combination of fuel cells with means for production of reactants or for treatment of residues with means for production of gaseous reactants
    • H01M8/0612—Combination of fuel cells with means for production of reactants or for treatment of residues with means for production of gaseous reactants from carbon-containing material
    • H01M8/0625—Combination of fuel cells with means for production of reactants or for treatment of residues with means for production of gaseous reactants from carbon-containing material in a modular combined reactor/fuel cell structure
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M8/00—Fuel cells; Manufacture thereof
    • H01M8/08—Fuel cells with aqueous electrolytes
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M8/00—Fuel cells; Manufacture thereof
    • H01M8/14—Fuel cells with fused electrolytes
    • H01M8/141—Fuel cells with fused electrolytes the anode and the cathode being gas-permeable electrodes or electrode layers
    • H01M8/142—Fuel cells with fused electrolytes the anode and the cathode being gas-permeable electrodes or electrode layers with matrix-supported or semi-solid matrix-reinforced electrolyte
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M8/00—Fuel cells; Manufacture thereof
    • H01M8/14—Fuel cells with fused electrolytes
    • H01M2008/147—Fuel cells with molten carbonates
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M2300/00—Electrolytes
    • H01M2300/0017—Non-aqueous electrolytes
    • H01M2300/0048—Molten electrolytes used at high temperature
    • H01M2300/0051—Carbonates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/50—Fuel cells
FR859596A 1961-01-24 1961-04-22 New drug, especially for the treatment of spasms of vascular origin. Active FR1407M (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR859596A FR1407M (en) 1961-01-24 1961-04-22 New drug, especially for the treatment of spasms of vascular origin.
BE616479A BE616479A (en) 1961-04-22 1962-04-16 Agents for the treatment of vascular spasms
US188226A US3165444A (en) 1961-04-22 1962-04-17 Compositions and method for the treatment of vascular spasms
GB15631/62A GB1014052A (en) 1961-04-22 1962-04-24 Therapeutically-active steroid compounds and pharmaceutical compositions incorporating them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR850596A FR1331326A (en) 1961-01-24 1961-01-24 New process for the preparation of bis-hydroxymethyl pregnane derivatives
FR859596A FR1407M (en) 1961-01-24 1961-04-22 New drug, especially for the treatment of spasms of vascular origin.

Publications (1)

Publication Number Publication Date
FR1407M true FR1407M (en) 1962-07-23

Family

ID=8747349

Family Applications (2)

Application Number Title Priority Date Filing Date
FR850596A Expired FR1331326A (en) 1961-01-24 1961-01-24 New process for the preparation of bis-hydroxymethyl pregnane derivatives
FR859596A Active FR1407M (en) 1961-01-24 1961-04-22 New drug, especially for the treatment of spasms of vascular origin.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR850596A Expired FR1331326A (en) 1961-01-24 1961-01-24 New process for the preparation of bis-hydroxymethyl pregnane derivatives

Country Status (7)

Country Link
BE (1) BE612981A (en)
BR (1) BR6235933D0 (en)
CH (1) CH409950A (en)
DE (1) DE1215707B (en)
ES (1) ES273977A1 (en)
FR (2) FR1331326A (en)
GB (1) GB988805A (en)

Also Published As

Publication number Publication date
DE1215707B (en) 1966-05-05
CH409950A (en) 1966-03-31
ES273977A1 (en) 1962-05-01
FR1331326A (en) 1963-07-05
BE612981A (en) 1962-07-23
BR6235933D0 (en) 1973-05-24
GB988805A (en) 1965-04-14

Similar Documents

Publication Publication Date Title
FR342M (en) New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR1407M (en) New drug, especially for the treatment of spasms of vascular origin.
FR1699M (en) New drug, especially for the treatment of spasms of vascular and visceral origin.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1508M (en) New drug in particular for the treatment of spasms of vascular origin.
FR1598M (en) New drug in particular for the treatment of spasms of vascular, coronary or visceral origin.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1418M (en) New drug for the treatment of coronary artery spasms.
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR55M (en) New drug, particularly for the treatment of coronary spasms
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR56F (en) New drug in particular for the treatment of spasms of coronary or vascular origin.
FR2053M (en) New drug in particular for the treatment of spasms of coronary or vascular origin.
FR1946M (en) New drug in particular for the treatment of spasms of coronary origin.
FR2681M (en) New drug in particular for the treatment of spasms of coronary origin.
FR133M (en) New dihydroxy drug, in particular for the treatment of spasms of coronary origin.
FR1886M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR129M (en) New acetoxylated drug for the treatment of spasms of coronary origin.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1961M (en) Compositions for the treatment of drug addiction.